Wyss Center for Bio and Neuroengineering
Celina Abi-Khalil, Ph.D. has extensive experience in regulatory affairs and healthcare industry. Celina has worked as a Clinical and Regulatory Affairs Manager at Wyss Center for Bio and Neuroengineering, held positions at Guerbet, Alispharm, and academic institutions, and has a strong educational background with a Ph.D. in Microbiology and Immunology. Their expertise lies in defining regulatory strategies for medical devices, managing interactions with regulatory bodies, and overseeing international registrations and sales authorizations.
Wyss Center for Bio and Neuroengineering
The Wyss Center is an independent, non-profit, research organization that innovates and accelerates technologies and therapies to transform the lives of people with neurological and mental health disorders. The Center pursues transformational technologies in artificial intelligence, bio- and neuroengineering to restore essential neural functions and deliver precision therapeutics for people with debilitating neurological and mental health disorders. Based at Campus Biotech in Geneva, Switzerland, the Wyss Center partners with faculty, clinicians and industry, in Switzerland and internationally, to drive innovation and maximize clinical impact. The Wyss Center was established by a generous donation from the Swiss entrepreneur and philanthropist Hansjörg Wyss in 2014. Additional resources from funding agencies and other sources help the Wyss Center achieve its mission. Subscribe to our updates - https://wysscenter.ch/newsletter